Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Harvard Bioscience, Inc.

Harvard Bioscience, Inc. (HBIO) Stock Overview

Explore Harvard Bioscience, Inc.’s financial performance, market position, analyst ratings, and future outlook.

HBIO●NASDAQ
HealthcareMedical - Instruments & Supplies
$7.55
$0.47(6.64%)
U.S. Market opens in 15h 35m

Harvard Bioscience, Inc. (HBIO)

Meyka AI Score

Z

Key Financials

Market Cap34.1M
P/E Ratio-3.02
EPS (TTM)$-0.36
ROE-0.92%
Fundamental Analysis

AI Price Forecasts

1 Month$6.38
3 Months$9.20
1 Year Target$3.70

HBIO Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Harvard Bioscience, Inc. (NASDAQ: HBIO) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Harvard Bioscience, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of HBIO on the NASDAQ shows an RSI of 72.35, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $3.70 for the NASDAQ listing.

Key metrics behind Harvard Bioscience, Inc.'s NASDAQ-traded stock include a P/E ratio of -3.02 and a market capitalization of 34.1M. Combined with our AI analysis, these give both institutional and retail investors a clear view of HBIO on the NASDAQ.

Price Performance (NASDAQ: HBIO)

1-Day Change
6.64%
5-Day Change
14.22%
1-Month Change
23.57%
3-Month Change
39.81%
6-Month Change
29.50%
Year-to-Date (YTD) Change
12.86%
1-Year Change
59.28%
3-Year Change
-81.85%
5-Year Change
-90.50%
All-Time (Max) Change
-90.59%

Contact Information

https://www.harvardbioscience.com
508 893 8999
84 October Hill Road, Holliston, MA, 01746

Company Facts

3,280 Employees
IPO DateDec 7, 2000
CountryUS
Actively Trading

Frequently Asked Questions